Ebos Group (NZSE:EBO) 3-Year EPS without NRI Growth Rate : 11.00% (As of Dec. 2023)

View and export this data going back to 1960. Start your Free Trial

What is Ebos Group 3-Year EPS without NRI Growth Rate?

Ebos Group's EPS without NRI for the six months ended in Dec. 2023 was NZ$0.78.

During the past 12 months, Ebos Group's average EPS without NRI Growth Rate was 11.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 11.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 9.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Ebos Group was 25.20% per year. The lowest was -16.90% per year. And the median was 9.70% per year.

Competitive Comparison of Ebos Group's 3-Year EPS without NRI Growth Rate

For the Medical Distribution subindustry, Ebos Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ebos Group's 3-Year EPS without NRI Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Ebos Group's 3-Year EPS without NRI Growth Rate falls into.

Ebos Group 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Ebos Group (NZSE:EBO) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Ebos Group 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Ebos Group's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group (NZSE:EBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (NZSE:EBO) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

EJG:Germany EBO:Australia

Address

108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (NZSE:EBO) Headlines

No Headlines